Pharmaceuticals

Global Anemia And Other Blood Disorder Drugs Industry Trends: Where the Market Is Headed by 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Anemia And Other Blood Disorder Drugs Market Expected To Become By 2029 Compared With Its 2025 Level?

The anemia and other blood disorder drugs market has seen substantial growth over recent years. Its size is expected to increase from $11.81 billion in 2024 to $12.46 billion in 2025, progressing at a compound annual growth rate (CAGR) of 5.5%. The expansion witnessed in prior periods is attributable to factors such as disease prevalence, global health initiatives, an aging population, pharmaceutical innovation, and heightened patient awareness.

The market for drugs addressing anemia and other blood disorders is projected to experience robust expansion over the coming years. This sector is forecast to reach $15.82 billion by 2029, expanding at a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this growth during the forecast period include the rise of emerging markets, shifts in global demographics, and various economic influences. Key trends anticipated during this period encompass sustained research and development efforts, significant technological advances, the emergence of biologics and targeted therapies, the advent of gene therapies, the increasing adoption of telemedicine and remote monitoring, the importance of orphan drug designations, and ongoing mergers and acquisitions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2465&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Anemia And Other Blood Disorder Drugs Industry?

A strong driving factor for the market is the increasing prevalence of anemia among the global population. Unhealthy lifestyles, changing dietary habits, and increased stress levels have contributed to a rise in anemia cases worldwide. For instance, anemia was identified as the most frequent disease in the elderly population (> 65 years of age), reaching a prevalence rate of around 17%. The World Bank reported that anemia is the 8th leading cause of disease among women and the young population. This growth in the prevalence rate of anemia subsequently drives the anemia and other blood disorder drugs market.

What Are The Emerging Segments Gaining Attention In The Anemia And Other Blood Disorder Drugs Market?

The anemia and other blood disorder drugs market covered in this report is segmented –

1) By Type: Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia

2) By Route of Administration: Oral, Injectable

3) By Distribution Channel: Hospitals Pharmacy, Online Pharmacy, Pharmacy

Subsegments:

1) By Iron Deficiency Anemia: Oral Iron Supplements, Injectable Iron Supplements, Iron Fortified Foods

2) By Chronic Kidney Disease Anemia: Erythropoiesis-Stimulating Agents (ESAs), Iron Supplements, Blood Transfusion

3) By Sickle Cell Anemia: Hydroxyurea, Blood Transfusions, Gene Therapy, Pain Management Drugs

4) By Aplastic Anemia: Immunosuppressive Therapy, Stem Cell Transplantation, Erythropoiesis-Stimulating Agents (ESAs)

Which Key Trends Are Expected To Influence The Anemia And Other Blood Disorder Drugs Market In The Coming Years?

Companies operating within the anemia and other blood disorder drugs market are forming partnerships with government agencies to develop and commercialize specific medications, pooling knowledge, technology, and financial resources. These alliances prove advantageous for companies, especially when dealing with expiring licenses and a strict regulatory landscape. For instance, in March 2023, Disc Medicine revealed a collaboration with the National Institutes of Health (NIH) and the National Heart, Lung, and Blood Institute (NHLBI) for the Phase 1/2 and Phase 2 clinical trials of biopterin in patients with Diamond-Blackfan Anemia (DBA), also aiming to treat adult patients suffering from iron deficiency anemia. The NIH will be responsible for conducting and funding these studies, as stipulated by a cooperative research and development agreement (CRADA).

Which Industry Leaders Are Driving Innovation Across The Anemia And Other Blood Disorder Drugs Market?

Major companies operating in the anemia and other blood disorder drugs market include Amgen Inc, GlaxoSmithKline plc, Akebia Therapeutics Inc., Bayer AG, Pfizer Inc, F. Hoffmann-La Roche Ltd., Merck Sharp & Dohme Corp., Novartis AG, Global Blood Therapeutics Inc., GlycoMimetics Inc., Eli Lilly and Company, FibroGen Inc., bluebird bio Inc., Acceleron Pharma Inc., AMAG Pharmaceuticals Inc., Pieris Pharmaceuticals Inc., Vifor Pharma Management Ltd., Sanofi S.A., Allergan U.S. Inc., Meda Consumer Healthcare Inc., AbbVie Inc., Johnson & Johnson, Daiichi Sankyo Company Limited, Galenica Ltd., Pharmacosmos A/S, Emmaus Medical Inc., Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb Company, Merck & Co. Inc., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., uniQure N.V., Rubius Therapeutics Inc., BioMarin Pharmaceutical Inc., Grifols S.A., Orchard Therapeutics plc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

How Does The Anemia And Other Blood Disorder Drugs Market Perform Across Key Geographic Regions?

North America was the largest region in the anemia and other blood disorder drugs market in 2024. Middle East is expected to be the fastest-growing region in the anemia and other blood disorder drugs market during the forecast period. The regions covered in the anemia and other blood disorder drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Anemia And Other Blood Disorder Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=2465&type=smp

Browse Through More Reports Similar to the Global Anemia And Other Blood Disorder Drugs Market 2025, By The Business Research Company

Anti Infective Drugs Market 2025

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Hospital Acquired Infections Testing Kits Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Anti Viral Drug Therapy Market 2025

https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795